E. Adeghate, P. Schattner, E. Dunn, O. Kusnik-joinville, A. Weill et al., An Update on the Etiology and Epidemiology of Diabetes Mellitus, Annals of the New York Academy of Sciences, vol.133, issue.6, pp.1-29, 2000.
DOI : 10.1016/S0899-9007(00)00550-5

S. Wannamethee, A. Shaper, M. Walker, B. Balkau, C. Lange et al., Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17beta-oestradiol or progesterone Independent influence of age on basal insulin secretion in nondiabetic humans European Group for the Study of Insulin Resistance, J Epidemiol Community Health Diabetologia Exp Physiol J Clin Endocrinol Metab, vol.59, issue.84, pp.134-139, 1999.

R. Bentley-lewis, K. Koruda, and E. Seely, The metabolic syndrome in women, Nature Clinical Practice Endocrinology & Metabolism, vol.19, issue.10, pp.696-704, 2007.
DOI : 10.1038/ncpendmet0616

I. Godsland, Oestrogens and insulin secretion, Diabetologia, vol.147, issue.Suppl 738, pp.2213-2220, 2005.
DOI : 10.1007/s00125-005-1930-0

A. Kanaya, D. Herrington, and E. Vittinghoff, Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial, Annals of Internal Medicine, vol.138, issue.1, pp.1-9, 2003.
DOI : 10.7326/0003-4819-138-1-200301070-00005

S. Salpeter, J. Walsh, T. Ormiston, E. Greyber, N. Buckley et al., Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women, Diabetes, Obesity and Metabolism, vol.35, issue.5, pp.538-554, 2006.
DOI : 10.1001/jama.279.18.1445

R. Rossi, G. Origliani, and M. Modena, Transdermal 17-??-Estradiol and Risk of Developing Type 2 Diabetes in a Population of Healthy, Nonobese Postmenopausal Women, Diabetes Care, vol.27, issue.3, pp.645-649, 2004.
DOI : 10.2337/diacare.27.3.645

Y. Zhang, B. Howard, and L. Cowan, The Effect of Estrogen Use on Levels of Glucose and Insulin and the Risk of Type 2 Diabetes in American Indian Postmenopausal Women : The Strong Heart Study, Diabetes Care, vol.25, issue.3, pp.500-504, 2002.
DOI : 10.2337/diacare.25.3.500

L. Gabal, D. Goodman-gruen, and E. Barrett-connor, The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus., American Journal of Public Health, vol.87, issue.3, pp.443-445, 1997.
DOI : 10.2105/AJPH.87.3.443

J. Manson, D. Nathan, A. Krolewski, M. Stampfer, W. Willett et al., A Prospective Study of Exercise and Incidence of Diabetes Among US Male Physicians, JAMA: The Journal of the American Medical Association, vol.268, issue.1, pp.63-67, 1992.
DOI : 10.1001/jama.1992.03490010065031

A. Fournier, A. Fabre, S. Mesrine, M. Boutron-ruault, F. Berrino et al., Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor???Defined Invasive Breast Cancer, Journal of Clinical Oncology, vol.26, issue.8, pp.1260-1268, 2008.
DOI : 10.1200/JCO.2007.13.4338
URL : https://hal.archives-ouvertes.fr/inserm-00271114

C. Saudek, W. Herman, D. Sacks, R. Bergenstal, D. Edelman et al., A New Look at Screening and Diagnosing Diabetes Mellitus, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.7, pp.2447-2453, 2008.
DOI : 10.1210/jc.2007-2174

W. Schofield, Predicting basal metabolic rate, new standards and review of previous work, Hum Nutr Clin Nutr, vol.39, issue.1, pp.5-41, 1985.

A. Thiebaut and J. Benichou, Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study, Statistics in Medicine, vol.6, issue.2, pp.3803-3820, 2004.
DOI : 10.1002/sim.2098

B. Ainsworth, W. Haskell, and M. Whitt, Compendium of Physical Activities: an update of activity codes and MET intensities, Medicine & Science in Sports & Exercise, vol.32, issue.Supplement, pp.498-504, 2000.
DOI : 10.1097/00005768-200009001-00009

P. Kopelman and L. Albon, Obseity, non-insulin-dependent diabetes mellitus and the metabolic syndrome, British Medical Bulletin, vol.53, issue.2, pp.322-340, 1997.
DOI : 10.1093/oxfordjournals.bmb.a011616

Z. Chen, T. Bassford, and S. Green, Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative, Am J Clin Nutr, vol.82, pp.651-656, 2005.

L. Chmouliovsky, F. Habicht, R. James, T. Lehmann, A. Campana et al., Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women, Maturitas, vol.32, issue.3, pp.147-153, 1999.
DOI : 10.1016/S0378-5122(99)00037-7

M. Gambacciani, M. Ciaponi, B. Cappagli, and A. Genazzani, Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women, American Journal of Obstetrics and Gynecology, vol.185, issue.5, pp.1180-1185, 2001.
DOI : 10.1067/mob.2001.117669

I. Thorneycroft, R. Lindsay, and J. Pickar, Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women???s Health, Osteoporosis, Progestin, Estrogen (HOPE) trial, American Journal of Obstetrics and Gynecology, vol.197, issue.2, pp.137-131, 2007.
DOI : 10.1016/j.ajog.2007.05.042

M. Sutter-dub, A. Ropero, E. Fuentes, B. Soria, C. Ripoll et al., Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women, Steroids Steroids Circulation, vol.6734, issue.102, pp.77-93, 2000.

B. Zegura, I. Keber, M. Sebestjen, and E. Borko, Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause, American Journal of Obstetrics and Gynecology, vol.188, issue.5, pp.1291-1296, 2003.
DOI : 10.1067/mob.2003.326

K. Pentti, M. Tuppurainen, and R. Honkanen, Hormone therapy protects from diabetes: the Kuopio Osteoporosis Risk Factor and Prevention Study Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up, Eur J Endocrinol Cochrane Database Syst Rev Br J Obstet Gynaecol, vol.3738, issue.104, pp.298-304, 1997.

H. Luotola, T. Pyorala, and M. Loikkanen, Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women, Maturitas, vol.8, issue.3, pp.245-253, 1986.
DOI : 10.1016/0378-5122(86)90032-0

B. Tehard, M. Van-liere, C. Nougue, C. Clavel-chapelon, and F. , Anthropometric Measurements and Body Silhouette of Women, Journal of the American Dietetic Association, vol.102, issue.12, pp.1779-1784, 2002.
DOI : 10.1016/S0002-8223(02)90381-0
URL : https://hal.archives-ouvertes.fr/inserm-00174519

H. Hr, 85] Duration of MHT use in ever-users 0-2 years 144, Model 1 a Model 2 b Case